Tweet
This might be something really good! Looking forward for further updates.
-
-
I think when a viable cure is actually found, we will all know about it. It will be front-page news. And, the cost won't be a big issue for many.Comment
-
More news to come...
There is no way they would have been able to find such a major partner with a huge funding with their 6 month results!
They must have had some kind of breakthrough at the 12th month follow-up which they made available to Shiseido and got them all excited!
Let's hope they will also release their latest trial results to the public unlike Aderans!Comment
-
Also guys its so sad to see Replicel managed to overtake Histogen and may actually come to market first, even though Histogen was at least 1 year ahead of them!
Replicel has finished their Phase 2b protocol and the trial will start in 2 months...Meanwhile, Histogen has remained silent for the last 6 months with no sign of a new protocol being written up or a planned timeline to conduct Phase 2b!
It looks like we may be waiting much longer for Histogen than originally expected
Comment
-
Always good to see you here Desmond, you bring reason to this board. I totally agree with your above reasoning and that's why I'm very excited about all this. A huge company only throws in big money like this when they think the technology has a good chance of becoming a success. Companies like this are no charities, they want to see results. Besides that I think Replicel can do a lot optimization and tweaking to get better results.Comment
-
I did not know anything about the 'Shiseido Company" so I did a little reading up on it. This little segment is from wiki-
"Shiseido Company, Limited, is a major Japanese hair care and cosmetics producer. It is one of the oldest cosmetics companies in the world. Founded in 1872, it celebrated its 140th year anniversary in 2012.It is the largest cosmetic firm in Japan and the fourth largest cosmetics company in the world."Comment
-
When I posted this I had the same thought, a big cosmetics company isn't gonna get involved without seeing promising results or evidence. I also agree with what you said about 'tweaking' Replicel have already done this once as they have changed their cell culturing protocol since the phase I testing. Loadsa people threw Replicel out and considered them a fail but I am very interested in their advancements and phase II trial.Comment
-
Didn't L'Oreal get involved with something suspect though?Comment
-
Did you really just mock someone for being bald, on the BALDtruth forums?????
Aren't we all bald here?...Oh wait I'm sorry.... I forgot that most of you on this website are paranoid 21 year olds who actually have full heads of hair.
If your not bald then get of the f***ing forum!Comment
-
Slow down with the optimism Des
They have milestones in place and will get awarded much much more than $4 Million if they can meet them.
It's no coincidence that they got just enough to stay afloat for some time while doing phase 2.
I think they may have simply been able to convince the Japanese that the phase 2 results will be much better if they can optimize the product.
Shiseido probably figure it's worth a try and invested an initial sum of money which is nothing to them, in exchange of a licensing agreement which if pahse 2 will go well will be worth billions.
This doesn't necessarily mean that Replicel have something more concrete for sure, but we well know they really think they do and think they can prove much better results in phase 2. Someone here on some threads was explaining to us they initially did some testing on mice and that went really well, and then they learned there were some particular things that make it a lot harder to grow hair in human they had not accounted for in phase 1, but still though they could overcome these difficulties.
We'll have to see what happens, but definitely it's good that Replicel is a more serious prospect than it was a few months ago!Comment
-
It would be a dream if Replicel were available at 1 year and a half as suggested by the Pipeline.
It is increasingly difficult to stay poisoning himself with drugs such as finasteride.Comment
Comment